Accès gratuit
Numéro
Med Sci (Paris)
Volume 22, Numéro 6-7, Juin-Juillet 2006
Page(s) 645 - 650
Section M/S revues
DOI https://doi.org/10.1051/medsci/20062267645
Publié en ligne 15 juin 2006
  1. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 1967; 70 : 891–9.
  2. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol 2003; 15 : 325–31.
  3. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes : genetic defects of apoptosis pathways. Cell Death Differ 2003; 10 : 124–33.
  4. Lavrik I, Golks A, Krammer PH. Death receptor signaling. J Cell Sci 2005; 118 : 265–7.
  5. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10 :26–35.
  6. Nagata S, Suda T. Fas and Fas ligand : lpr and gld mutations. Immunol Today 1995; 16 : 39–43.
  7. Pestano GA, Zhou Y, Trimble LA, et al. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 1999; 284 : 1187–91.
  8. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268 : 1347–9.
  9. Benkerrou M, Le Deist F, de Villartay J, et al. Correction of fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol 1997; 27 : 2043–7.
  10. Rieux-Laucat F, Blachere S, Danielan S, et al. Lymphoproliferative syndrome with autoimmunity : a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999; 94 : 2575–82.
  11. Vaishnaw AK, Orlinick JR, Chu JL, et al. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest 1999; 103 : 355–63.
  12. Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001; 98 : 2466–73.
  13. Drappa J, Vaishnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335 : 1643–9.
  14. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas : genotype influences penetrance. Am J Hum Genet 1999; 64 : 1002–14.
  15. Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11 : 131–9.
  16. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98 : 47–58.
  17. Gronbaek K, Dalby T, Zeuthen J, et al. The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 2000; 95 : 2184–5.
  18. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419 : 395–9.
  19. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307 : 1465–8.
  20. Salmena L, Lemmers B, Hakem A, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17 : 883–95.
  21. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004; 351 : 1409–18.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.